Multiple Electrode Vectors for Implantable Cardiac Treatment Devices
AssigneeCameron Health, Inc.
InventorsJay A. Warren, Gust H. Bardy
Life of this patent
Estimating the term…
Loading patent…
AssigneeCameron Health, Inc.
InventorsJay A. Warren, Gust H. Bardy
Estimating the term…
The implantable cardiac treatment system of the present invention is capable of choosing the most appropriate electrode vector to sense within a particular patient. In certain embodiments, the implantable cardiac treatment system determines the most appropriate electrode vector for continuous sensing based on which electrode vector results in the greatest signal amplitude, or some other useful metric such as signal-to-noise ratio (SNR). The electrode vector possessing the highest quality as measured using the metric is then set as the default electrode vector for sensing. Additionally, in certain embodiments of the present invention, a next alternative electrode vector is selected based on being generally orthogonal to the default electrode vector. In yet other embodiments of the present invention, the next alternative electrode vector is selected based on possessing the next highest quality metric after the default electrode vector. In some embodiments, if analysis of the default vector is ambiguous, the next alternative electrode vector is analyzed to reduce ambiguity.
A method of cardiac signal analysis in an implantable medical device comprising a canister and a lead system, the implantable medical device including at least first, second and third electrodes, and being configured such that one or more pairs of electrodes can be selected for use in cardiac signal sensing, the method comprising:
An implantable cardiac therapy system (ICTS) comprising:
An implantable cardiac therapy system (ICTS) comprising:
Dependencies are inferred from the claim text.